Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innov. LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 3.375p 3.25p 3.50p 3.375p 3.375p 3.375p 338,132 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 5.5 -2.1 -0.4 - 16.49

Surgical Innovations (SUN) Latest News

More Surgical Innovations News
Surgical Innovations Takeover Rumours

Surgical Innovations (SUN) Share Charts

1 Year Surgical Innovations Chart

1 Year Surgical Innovations Chart

1 Month Surgical Innovations Chart

1 Month Surgical Innovations Chart

Intraday Surgical Innovations Chart

Intraday Surgical Innovations Chart

Surgical Innovations (SUN) Discussions and Chat

Surgical Innovations Forums and Chat

Date Time Title Posts
24/10/201608:36(Surging) Surgical Innovations3,854
25/3/201622:13Surgical Innovations : A New BOD & A New Future6
14/2/201221:44Where's the thread gone?1
04/10/201109:25Surgical Innovation...cutting edge technology5,573

Add a New Thread

Surgical Innovations (SUN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
25/10/2016 12:26:203.402,63189.45O
25/10/2016 12:26:203.402,36180.27O
25/10/2016 12:25:473.3550,0001,675.00O
25/10/2016 12:25:473.5050,0001,750.00O
25/10/2016 10:20:133.2586,8482,822.56O
View all Surgical Innovations trades in real-time

Surgical Innovations (SUN) Top Chat Posts

Surgical Innovations Daily Update: Surgical Innov. is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker SUN. The last closing price for Surgical Innovations was 3.38p.
Surgical Innov. has a 4 week average price of 2.84p and a 12 week average price of 2.52p.
The 1 year high share price is 3.53p while the 1 year low share price is currently 1.18p.
There are currently 488,681,435 shares in issue and the average daily traded volume is 2,160,584 shares. The market capitalisation of Surgical Innov. is £16,492,998.43.
leadingladies: Have a quick look through the previous announcements and can see one example where he invested £1.5m - see below Wonder if Doug Liversidge still holds ?? I still worry that there is absolutely no news on orders / development etc coming out of the company at all. It cannot be that expensive to update the website surely. A question for the next AGM I think !
leadingladies: 66m shares at a loss of circa 3p / share = a lot of money!!! Struggling to understand the logic behind. OK if he sold half believing this would encourage new investors who would bring the company on and increase the share price (and hence the value of the remaining half) but this baffles me. Can only assume he has a better home for his money !
bjfanc: MM's having fun. Share price walked down, no sellers.
leadingladies: Post loan note conversion likely they will have close to 50% between them. Unsure if cozy deals can then be brokered between the 2 parties to take single holder over 50% but that worries me. More worrying in the short term is the total absence of any news over sales / orders etc. As said in a previous post not in Mr Reas / Getz's interest to have the share price any higher until notes converted so maybe a factor. Would be good however to have somebody on this board with inside information (current / ex employees etc). As an aside looked at list of directors associated with Mr Rea's main company AESSEAL plc. Quite a lot of them which "possibly blindly" makes me think he isn't solely out for individual gain.
mandate: In fact, this is the perfect time to bring in someone from the outside. argyle, at the time, the reward of selling those shares was probably appropriate - he had, after all, taken the share price from 2p to between 10p and 13p.
meijiman: I note that for around one year from June 2011 to May 2012 the share price was mainly above 10p. if you got in at a low point before that point and sold at over 10p then you may well have made a decent profit. So what has happened after that point to collapse earnings and when will earnings recover? If you have rebuilt your position you must have done so in the expectation of good news and a return to the glory days of plus 10p. Yet you are very reticent in sharing you optimistic views with others.
gnnmartin: I don't think that they are in danger of being taken over. From several visits at AGMs over the years I reckon they have good advisers and a core of supportive shareholders. I think the share price is a reasonable compromise between hope and disappointment. The trailing PE is 25 (according to ADVFN, which I know is unreliable, and I haven't checked) and we know that this year's profits will be hit, so the PE will rise. The USA is always a tough market to enter, and the reorganisation of the production (from overseas to in house) is tough but the right thing to do (IMO). There is enormous potential for the company in the USA especially. What you think the share price should be depends on how likely you think it is they will realise that potential. I certainly had hoped that they would be making more money by now, but the slide from 11p down to 4.25p reflects that disappointment. I do think they need to start making money soon, or else shortage of money will be a problem. I don't think success in the USA is dependant on the new facility, so if there is any delay there, it is not bad news. Nigel Martin
meijiman: It would be interesting to know what you don't like about the company (as per your post)but again that is a matter for you to either share or not share. Equally it would be interesting to know whether management take note of any concerns. I have formed a view that shareholder views/the share price does not greatly matter. If you had Blackrock and Schroders say on your register and you were summoned in to meet them twice a year, it might concentrate your mind a bit more on the share price performance.
darrin1471: I would not dispute that SUN has potential for significant growth especially in the US over the next few years. SI branded sales were £1.589m in H1 I would suggest that SUN has already taken the low hanging fruit by moving production in house and increasing sales to existing OEM customers. Mkt cap is already double sales forecasts for 2010. The p/e will be around 11x if profits are £1.5m for the full year. £1.5m for the FY will be a good result. In H1 2011 SI own brand and OEM sales will need to continue growth at existing rates just to cover the £616k industrial order. imo successful entry into the US markets is already priced into the SUN share price. Evidence of a successful entry into the US and the potential of growth over a number of years will lead to a higher p/e and share price but this should not happen before SUN produces the evidence. A p/e of 20+ can not be justified looking at SUN's history. I wish SUN and shareholders success in the future and hope to have the opportunity to buy back in at sub 4p in 9-12 months time.
Surgical Innovations share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20161026 04:06:08